Stocks Hitting 52-Week Highs - Exelixis (NASDAQ:EXEL)

Las Vegas Sands Corp. LVS shares gained 1.6 percent to reach a new 52-week high of $57.45. Argus Research upgraded Las Vegas Sands from Hold to Buy.
Vitae Pharmaceuticals Inc VTAE shares climbed 158 percent to touch a new 52-week high of $20.89. Allergan plc AGN and Vitae Pharmaceuticals reached an agreement by which the former would buy the latter for $21.00 a share in cash.
Exelixis, Inc. EXEL shares touched a new 52-week high of $13.11 after the company disclosed that the EC has approved CABOMETYX tablets for the treatment of advanced renal cell carcinoma following VEGF-targeted therapy.
Seattle Genetics, Inc. SGEN shares rose 4.5 percent to touch a new 52-week high of $54.01. Seattle Genetics shares have climbed 10.49 percent over the past 52 weeks, while the S&P 500 index has increased 8.91 percent in the same period.